ALAMAB THERAPEUTICS
About:
AlaMab is a clinical stage biopharmaceutical company.
Website: https://alamab.com/
Description:
AlaMab provides antibody drugs. They also provide commercializing novel monoclonal antibody therapeutics to benefit patients suffering from indications with significant unmet treatment needs.
Total Funding Amount:
$11.8M
Headquarters Location:
Princeton, New Jersey, United States
Founded Date:
2017-01-01
Founders:
Number of Employees:
1-10
Last Funding Date:
2017-08-02
IPO Status:
Private
Industries:
© 2025 bioDAO.ai